Novità in dislipidemiaUltimo aggiornamento: Martedì 03 Dicembre 2024
Kestecher Brachyahu M. et al. | Cardiovascular Diabetology 2024; 23(1):...
All mouse experiments followed procedures outlined by the Council Directive of the European Union (86/609/EEC),...
von Känel-Cordoba Isabel et al. | Journal of Health, Population and Nutrition...
Chronic diseases represent a significant global health challenge. Approximately one-third of adults worldwide...
Zhao Mengjie et al. | Lipids in Health and Disease 2024; 23(1):...
Diabetes mellitus (DM), a global health challenge, is characterized by high prevalence, low treatment...
Yu Bian
et al. | British Journal of Pharmacology 2024;...
Existing medications for hyperlipidaemia are limited by the adverse effect of liver damage.
Return...
Jiang Li et al. | Cardiovascular Diabetology 2024; 23(1):...
Diabetes mellitus, particularly type 2 diabetes mellitus (T2DM), is a growing global health concern and...
Koutaro
Yokote
MD et al. | Journal of the American Heart Association...
Evolocumab was safe and effective in Japanese patients with homozygous/heterozygous familial hypercholesterolemia...
Lyu Xuan et al. | BMC Cardiovascular Disorders 2024; 24(1):...
Familial hypercholesterolemia (FH) is a classic autosomal dominant hereditary disease, primarily caused...
Song Kaimin et al. | BMC Infectious Diseases 2024; 24(1):...
Despite the availability of safe and effective hepatitis B vaccine, hepatitis B virus (HBV) infection...
Canbay Erhan et al. | Lipids in Health and Disease 2024; 23(1):...
Oxysterols are oxidized derivatives of cholesterol that play significant roles in various biological...
Ricerca bibliograficaConcentrati e scegli la tua ricerca di dati scientifici
Ricerca per revisione
1097 articoli attualmente disponibili
Ricerca per argomento
Top articlesArticoli più letti
von Känel-Cordoba Isabel et al. | Journal of Health, Population and Nutrition...
Chronic diseases represent a significant global health challenge. Approximately one-third of adults worldwide are affected by multiple chronic conditions, including cardiovascular diseases, diabetes, depression,...
Kestecher Brachyahu M. et al. | Cardiovascular Diabetology 2024; 23(1):...
All mouse experiments followed procedures outlined by the Council Directive of the European Union (86/609/EEC), and prior to experimental work, approval was granted by Semmelweis University’s Institutional...
Zhao Mengjie et al. | Lipids in Health and Disease 2024; 23(1):...
Diabetes mellitus (DM), a global health challenge, is characterized by high prevalence, low treatment rates, and high mortality, exerting a heavy burden on individual health and the global health system....
Yu Bian
et al. | British Journal of Pharmacology 2024;...
Existing medications for hyperlipidaemia are limited by the adverse effect of liver damage.
Return to the table of contents...
Koutaro
Yokote
MD et al. | Journal of the American Heart Association...
Evolocumab was safe and effective in Japanese patients with homozygous/heterozygous familial hypercholesterolemia and hypercholesteremia with high risk in real‐world practice.
Low incidence rates...